Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
ID: 353596Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353596

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-130.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the grant opportunity titled "Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults," aimed at enhancing sleep interventions for individuals aged 12-25 who are at risk for mental health disorders. This initiative seeks pilot research proposals that will adapt, optimize, and empirically test behavioral interventions to address sleep problems, focusing particularly on feasibility, acceptability, and effectiveness in real-world settings, with an emphasis on underserved populations. The program is critical for developing scalable, evidence-based solutions to improve sleep and mental health outcomes among youth, with a total funding amount of up to $1.5 million available to support up to six grants, each capped at $450,000 over three years. Interested applicants must submit their proposals by September 30, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-MH-25-130-Full-Announcement.html
    RFA-MH-25-130.html
    The Department of Health and Human Services, through the National Institute of Mental Health (NIMH), is soliciting applications for pilot research aimed at optimizing behavioral sleep interventions for adolescents and young adults (ages 12-25) at risk for mental health disorders. This funding opportunity, titled "Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults," seeks to evaluate the feasibility, acceptability, and potential effectiveness of these interventions in real-world settings. Applicants are encouraged to focus on underserved populations and include a diverse team of experts. Key dates include the application due date of September 30, 2024, and an anticipated budget of $1.5 million to support up to six grants, each with a maximum budget of $450,000 over a three-year period. Applications must detail plans for assessing mechanisms linking sleep and mental health, as well as strategies to promote broad access to interventions. Research proposals that align with NIMH's mission of addressing mental health disparities will be prioritized. Overall, this initiative reflects a strategic effort to develop scalable, evidence-based sleep interventions specifically tailored for adolescents and young adults, addressing a significant public health concern in relation to sleep and mental health.
    Similar Opportunities
    Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)" aimed at addressing sleep health disparities among underserved populations through non-pharmacological interventions. The initiative seeks to support research that examines sleep as a modifiable factor influencing health disparities, particularly focusing on populations such as Black/African American, Hispanic/Latino, and other socioeconomically disadvantaged communities. This funding opportunity encourages diverse research methodologies, including randomized controlled trials, to explore effective interventions while emphasizing collaboration with affected communities to ensure culturally relevant outcomes. Applications are due by September 7, 2027, and interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-110.html.
    Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)." This grant aims to support basic science experimental studies involving human participants that explore the mechanisms linking sleep and circadian rhythms with substance use disorders (SUDs), emphasizing the need for innovative approaches and diverse research teams. The funding, totaling approximately $2 million, is available for multiple research projects over five years, with applications due by October 29, 2024. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)." This grant aims to support basic science experimental studies that enhance understanding of the connections between sleep/circadian rhythms and substance use disorders (SUDs), with a focus on identifying biological mechanisms and potential therapeutic targets. The total funding commitment for this initiative is $2 million, with an expected allocation of approximately three to five awards, and applications are due by October 30, 2024. Interested applicants can find more information and submit proposals electronically via Grants.gov, and they are encouraged to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research efforts.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). This initiative aims to support innovative clinical trials that investigate novel interventions for mental health conditions, including schizophrenia, depression, and anxiety, with a focus on establishing proof of mechanism and target engagement in the R61 phase and confirming findings on a larger scale in the R33 phase. The total funding commitment for this initiative is $27 million for FY 2022, and eligible applicants include a diverse range of entities such as higher education institutions, nonprofits, and various government organizations, both domestic and foreign. Interested parties should note that the application deadline is October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.
    Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes" grant, aimed at evaluating therapeutic and service delivery innovations for managing mental health conditions following acute treatment. Applicants are required to conduct pilot trials that assess the feasibility, acceptability, safety, and preliminary effectiveness of interventions designed to improve long-term mental health outcomes, particularly for underserved populations. This initiative underscores the importance of advancing mental health research and fostering effective care transitions beyond acute care settings. Eligible organizations can apply for funding of up to $450,000 over three years, with applications due by January 25, 2025. For further information, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33 - Clinical Trial Required). This funding opportunity aims to support early-stage clinical trials that evaluate novel pharmacologic or device-based interventions targeting mental disorders such as depression, schizophrenia, and anxiety, with a focus on interventions that demonstrate unique mechanisms of action and potential clinical benefits. The NIH intends to commit $27 million in funding, and proposals must include clinical trial designs with budgets reflecting actual project needs over a maximum period of three years, emphasizing innovative interventions that address unmet therapeutic needs. Interested applicants can find more information and guidelines at the NIH website, with a submission deadline of October 15, 2024.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications," aimed at advancing the development of innovative brain stimulation devices for mental health treatment. This grant supports projects that either create novel brain stimulation technologies or significantly enhance existing FDA-approved devices, focusing on improving spatial and temporal precision and enabling multi-focal approaches for effective treatment delivery. The initiative is crucial for addressing clinical limitations in mental health technologies and encourages collaboration among multidisciplinary teams with expertise in neuroscience, engineering, and regulatory affairs. Interested applicants can apply for up to $275,000 over a two-year project period, with applications due by January 7, 2025. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-038.html.